1. Home
  2. RDHL vs KRKR Comparison

RDHL vs KRKR Comparison

Compare RDHL & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • KRKR
  • Stock Information
  • Founded
  • RDHL 2009
  • KRKR 2010
  • Country
  • RDHL Israel
  • KRKR China
  • Employees
  • RDHL N/A
  • KRKR N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • RDHL Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • RDHL 8.2M
  • KRKR 6.6M
  • IPO Year
  • RDHL N/A
  • KRKR 2019
  • Fundamental
  • Price
  • RDHL $5.85
  • KRKR $6.10
  • Analyst Decision
  • RDHL
  • KRKR
  • Analyst Count
  • RDHL 0
  • KRKR 0
  • Target Price
  • RDHL N/A
  • KRKR N/A
  • AVG Volume (30 Days)
  • RDHL 10.8K
  • KRKR 1.3M
  • Earning Date
  • RDHL 08-29-2024
  • KRKR 09-03-2024
  • Dividend Yield
  • RDHL N/A
  • KRKR N/A
  • EPS Growth
  • RDHL N/A
  • KRKR N/A
  • EPS
  • RDHL N/A
  • KRKR N/A
  • Revenue
  • RDHL $3,707,000.00
  • KRKR $41,654,350.00
  • Revenue This Year
  • RDHL $224.90
  • KRKR $45.99
  • Revenue Next Year
  • RDHL $82.69
  • KRKR $31.46
  • P/E Ratio
  • RDHL N/A
  • KRKR N/A
  • Revenue Growth
  • RDHL N/A
  • KRKR N/A
  • 52 Week Low
  • RDHL $5.41
  • KRKR $2.76
  • 52 Week High
  • RDHL $20.28
  • KRKR $12.99
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.71
  • KRKR 59.72
  • Support Level
  • RDHL $5.76
  • KRKR $4.99
  • Resistance Level
  • RDHL $6.26
  • KRKR $7.00
  • Average True Range (ATR)
  • RDHL 0.33
  • KRKR 1.48
  • MACD
  • RDHL 0.01
  • KRKR 0.17
  • Stochastic Oscillator
  • RDHL 20.17
  • KRKR 30.19

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: